New Discount Opportunity for CPP Members

One of the most important elements of vaccine storage is utilizing an accurate temperature monitoring device that has been properly maintained.

According to the CDC Vaccine Storage & Handling Toolkit:

Calibration testing should be done every one to two years or according to the manufacturer’s suggested timeline. TMDs can experience a “drift” over time, affecting their accuracy. This testing ensures the accuracy of the device continues to conform to nationally-accepted standards.

If you need to replace the temperature monitoring device at your practice or if the cost of calibration testing outweighs the cost of purchasing a new device, CPP members can access a discount on LogTag Vaccine Temperature Monitoring Kits.  Simply contact the CPP office at for more information.

Merck’s Pediatric Recombivax HB Available March 9, 2020

As announced at the ACIP meeting last week, supply of the pediatric formulation of Merck’s Recombivax HB will be returning to the private sector.  The following vaccine presentations will be available for purchase beginning March 9, 2020:   

CPP members can purchase Merck vaccines directly from Merck or through a Merck Vaccines Prime Distributor to receive the CPP member discounts.        

At this time, the adult formulations of Recombivax HB are still unavailable.  You can keep up on supply updates by visiting the Merck Supply Status website.  Remember, CPP members can access a discount on Dynavax’s Heplisav-B, a 2-dose hepatitis B vaccine series for adult patients.  To participate in this discount opportunity, contact the CPP office to request an opt-in form.  Once your practice is linked to the CPP member discount, doses can be purchased through an authorized distributor of Heplisav-B.   

If you have any questions or would like additional information, please contact the CPP Office at 614-722-2145 or your Merck representative.

Shared Clinical Decision-Making: Understanding the Recommendations from the CDC

The immunization schedules for 2020 recently published by the Center for Disease Control (CDC) four recommendations for vaccination based on shared clinical decision-making. These vaccines are:

  • Meningococcal B (MenB) vaccination for adolescents and young adults aged 16–23 years
  • Human papillomavirus (HPV) vaccination for adults aged 27–45 years
  • Pneumococcal conjugate vaccination (PCV13) for adults aged 65 years and older who do not have an immunocompromising condition, cerebrospinal fluid leak, or cochlear implant
  • Hepatitis B (HepB) vaccination for adults age 60 years and older with diabetes mellitus

But what is a shared clinical decision-making recommendation? According to the CDC, an immunization is given this designation when it is not indicated for all members of a population. The vaccination may benefit some members of the age or risk group, but broad vaccination of people in that group is unlikely to have population-level impacts. For shared clinical decision-making immunizations, patients and providers should discuss the potential benefits of vaccination and come to a personalized decision together.

Over the next month, we will examine the individual immunizations that the ACIP recommends for shared clinical decision-making.


The HPV vaccination is routinely recommended for ages 11 or 12 with catch-up recommendations for those not vaccinated on time.

In June 2019, the ACIP recommended shared clinical decision-making for HPV vaccination of adults aged 27–45 years. According to the ACIP Shared Clinical Decision-Making Recommendations, HPV acquisition generally occurs soon after first sexual activity. Vaccine effectiveness is lower in older age groups because of prior infections and lower risk of exposure (for example, among persons who are in a long-term, mutually monogamous sexual partnership). The ACIP recommended shared clinical decision-making rather than catch-up vaccination because most adults in this age group would have no or minimal benefits from vaccination. However, some individuals who are not already immune to HPV through vaccination or natural infection (e.g., a previously unvaccinated person who has never had sex) and who might be at risk for acquiring a new HPV infection in the future (e.g., plans to have sex with a new partner in the future) might benefit from vaccination.

A detailed explanation of the ACIP’s recommendation and considerations for shared clinical decision making regarding HPV vaccination of adults aged 27 through 45 years can be found on the HPV Updated Recommendations webpage.

Vaccine Price Updates for 2020

Most vaccines have new pricing in 2020.  Here is a summary of the effective dates for all of CPP’s vendor partners:

  • Merck – effective 10/31/2019
  • Sanofi Pasteur – effective 1/1/2020
  • Pfizer – effective 2/27/2020

Pfizer has announced updated pricing on Trumenba (and Prevnar 13) that went into effect January 1, 2020. There will be a discount period when members can place orders for these vaccines at the pre-increase price until February 26, 2020 (with delivery no later than February 28, 2020). If you would like electronic or hard copies of the updated pricing sheet for Trumenba, please contact the CPP office.

In addition, the CDC has updated its Vaccine Price List for 2020. Prices are current as of January 1, 2020. To find out more and access the list, visit

Managing a financially sustainable vaccine program is key to providing the most value to your practice and your patients.  This would include checking your invoices to make sure you’re being charged correctly, checking your billing to make sure your billing rates are adjusted to account for the price changes and checking your insurance payments to make sure they have adjusted accordingly.  CPP offers several price change management resources that are posted on the CPP Resources Webpage to help members manage through vaccine price changes. 

Please contact the CPP office at 614-722-2145 with questions.

2020-2021 Flu Vaccine Pricing & Pre-Book Details

For the upcoming 2020-2021 flu season, CPP members will have two opportunities to save on influenza vaccines:

SANOFI PASTEUR:  CPP members who confirm their flu vaccine reservation on by the March 31, 2020 deadline will receive the discounted member pricing, delivery commitments and returns allowance.  Please also note that CPP members can now earn an additional 1% rebate from CPP on all Sanofi Pasteur flu vaccine purchases!  To receive these benefits, make sure your Sanofi Pasteur account is linked to the CPP member pricing and confirm your reservation through by the deadline.

ASTRAZENECA:   Members who wish to pre-book FluMist doses will have an opportunity to purchase them at a discount, receive a returns allowance and a supply commitment.  To receive these benefits, confirm that the DEA # for your practice is linked to CPP by submitting a declaration form and pre-book your FluMist doses through your preferred authorized distributor by January 31, 2020 (Early Pre-Book for a larger discount) or March 31, 2020 (Standard Pre-Book).  Declaration forms can be obtained by contacting the CPP office.

For pricing other details, please don’t hesitate to contact the CPP office at 614-722-2145 or

Updated Vaccine Information Statements

Did you know that many Vaccine Information Statements were updated recently? This list below provides the current dates of VISs:

If your VISs are not current, these links will lead you to the current statements: Is this CDCs main hub for Vaccine Information Statements. Find instructions for use, FAQs, and current statements here. Provides quick links to all current VISs and access to multiple languages.

Creating a Culture of Immunization: Resources for Your Practice

All staff in a pediatric practice, including non-clinical staff, play an important role in supporting parents in their immunization decisions. Creating a culture of immunization in your office helps promote complete and timely immunizations. To that end, the CDC and Sanofi Pasteur have produced helpful resources to aid in building a pro-vaccination culture.

The CDC has created presentation available for download called “10 Ways to Create a Culture of Immunization Within Our Pediatric Practice.” The presentation is editable and designed to be customized by each medical practice. The objectives of the presentation are to enable office staff to

  • Understand why practices need a culture of immunization
  • Cite the practice’s current immunization coverage rates
  • Describe how all office staff play a part in creating a culture of immunization
  • Describe several ways to create a culture of immunization

The presentation is easy to customize and contains notes to help guide the discussion.

Another useful resource is the handout “Developing an Immunization Culture in Your Office” by Sanofi Pasteur. This handout breaks down broad ideas concerning immunization culture into succinct, actionable bullet points. It instructs staff to

  • Educate and Motivate Your Staff to Become Vaccine Advocates
  • Capture Every Opportunity to Immunize
  • Prioritize parental education and communication
  • Put technology to work as a tracking tool

Both of these resource will assist your practice in increasing immunization rates by creating an office-wide culture of vaccination.

Adolescent Immunization Resources

The Immunization Action Coalition and Sanofi Pasteur have collaborated a project to raise awareness of the low immunization rates for the meningococcal (MenACWY) vaccination. The project, titled “MenACWY: You’re Not Done if You Give Just One,” can be found at and contains a wealth of resources for medical practices.

The facts are stark: Meningococcal disease can be deadly, and survivors can suffer lifelong disabilities from contracting the disease. Unfortunately, the majority of administration opportunities are missed. Even during vaccine only visits, 86% of adolescents were not given MenACWY. 1

The recommended administration guidelines are to give the initial dose at 11-12 years of age and the second dose at 16 years of age. This factsheet provides important information about recommending and administering MenACWY.

Another helpful resource from the MenACWY project is the “Top 10 Ways to Improve Adolescent Immunization Rates” handout. The top 10 are:

  1. Immunize at every opportunity by considering every visit an opportunity to vaccinate.
  2. Use reminder and recall systems to automatically remind families of needed immunizations.
  3. Implement standing orders to allow nurses, pharmacists, and other healthcare personnel to vaccinate.
  4. Take part in an immunization registry to access comprehensive immunization records for every patient.
  5. Review your patients’ vaccination histories prior to visits and flag charts as indicated.
  6. Follow the U.S. recommended immunization schedule.
  7. Schedule vaccination-only quick visits to increase access for patients.
  8. Make vaccination education a priority, for parents as well as patients.
  9. Establish rapport with your adolescent patients by taking a nonjudgmental approach and being ready to listen and answer questions.
  10. Create a culture that values well-adolescent care by maintain the same set of high expectations you take with well-child visits.

Visit the “MenACWY: You’re Not Done if You Give Just One” website at   for these and other great resources.

In the upcoming months, CPP will continue posting resources on increasing adolescent immunization rates and creating a culture of vaccination in your practice. Subscribe to our blog to stay up to date.

1. Wong CA. Taylor JA, Wright JA, et al. Missed opportunities for adolescent vaccination, 2006–2011. J Adolesc Health. 2013;53(4):492–497.

CDC Webinar – Strategies for Addressing Vaccine Misinformation in the Practice

On Wednesday, August 28, the CDC will be hosting a webinar from 1-2pm to assist providers in recommending vaccines and addressing vaccine hesitancy.

Speakers for the webinar include:

  • Dr. Amanda Cohn, Acting Chief Medical Officer, Vaccine Policy, Preparedness, Global Health, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention
  • Chanie Sternberg, President & CEO, RefuahHealth Center
  • Dr. Corinna Manini, Chief Medical Officer, RefuahHealth Center
  • Dr. Todd Wolynn, CEO, Kids Plus Pediatrics

RefuahHealth is a health center in New York that serves patients in communities affected by ongoing measles outbreaks. They have worked to cultivate trust with parents concerning the safety and efficacy of vaccines.

Follow this link for more information and to register. Don’t wait to register for this timely and relevant information. And stay tuned to the CPP Blog. In the next few months, we will be posting a series on addressing vaccine hesitancy in your practice. Subscribe to our blog to stay up to date!

Group purchasing: Save money by aligning with other physicians

Medical Economics recently published an article highlighting the benefits of partnering with a group purchasing organization (GPO) or physician buying group (PBG). Practices can expect savings ranging from 5 percent to 25 percent by joining such a group. Highlights include:

  • Don’t base your GPO choice on what your hospital uses. Physician offices have different needs than hospitals. Find a group that fits your specific needs.
  • Revisit pricing every year or two and compare groups. The needs of a practice can change over time, and there is no one size fits all solution.
  • Know the difference between a GPO and PBG. GPOs are membership organizations that offer discounts on most everything involved in a medical practice such as capital equipment, supplies, and services. PBGs also offer discounts on supplies and services, but they primarily serve as vaccine buying groups. Due to their vaccine focus, PBGs are able to provide superior pricing.
  • Let your vendors do the work of pricing. Put your top purchased items out for bid to ensure you are getting the best price.
  • Check if your distributor performs additional services like stocking and ordering supplies.

To read more, visit Medical Economics online.